Not applicableStudy completedNCT02620254What this trial is testingMast Cell Connect: A Registry for Patients With MastocytosisWho this might be right forMastocytosis Blueprint Medicines Corporation 743
Testing effectiveness (Phase 2)Study completedNCT00782067What this trial is testingEfficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell LeukemiaWho this might be right forLeukemia Novartis Pharmaceuticals 116
Not applicableLooking for participantsNCT07143669What this trial is testingScreening Study for KIT D816V Mutated Mast Cell Disease in Select PopulationsWho this might be right forClonal Mast Cell DiseaseKIT D816V MutationSuspected KITD816V Mutated Clonal Mast Cell Disease Blueprint Medicines Corporation 450
Not applicableStudy completedNCT00899795What this trial is testingEvaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy VolunteersWho this might be right forLeukemiaMyelodysplastic Syndromes OHSU Knight Cancer Institute 35
Not applicableLooking for participantsNCT06295965What this trial is testingClonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES StudyWho this might be right forRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+7 more University of Washington 2,000
Testing effectiveness (Phase 2)Study completedNCT01036009What this trial is testingWithdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic MalignanciesWho this might be right forAcute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+7 more University of California, San Francisco 43
Testing effectiveness (Phase 2)Study completedNCT01807598What this trial is testingBrentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell LeukemiaWho this might be right forAggressive Systemic MastocytosisMast Cell LeukemiaSystemic Mastocytosis Jason Robert Gotlib 10
Testing effectiveness (Phase 2)Looking for participantsNCT06566742What this trial is testingStudy Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.Who this might be right forMyelodysplastic SyndromesChronic Myelomonocytic LeukemiaClonal Cytopenia of Undetermined Significance M.D. Anderson Cancer Center 15
Large-scale testing (Phase 3)Study completedNCT03106779What this trial is testingStudy of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIsWho this might be right forChronic Myelogenous Leukemia Novartis Pharmaceuticals 233
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191What this trial is testingInvestigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)Who this might be right forPhiladelphia Chromosome-Positive Chronic Myeloid Leukemia Novartis Pharmaceuticals 568
Not applicableStudy completedNCT02380222What this trial is testingPatient-Reported Outcome Questionnaire for Systemic MastocytosisWho this might be right forAggressive Systemic Mastocytosis (ASM)SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD)Mast Cell Leukemia (MCL)+2 more Adelphi Values LLC 5
Not applicableActive Not RecruitingNCT04902833What this trial is testingAcquired Pyruvate Kinase Deficiency In Clonal Myeloid NeoplasmsWho this might be right forPyruvate Kinase DeficiencyPyruvate Kinase Deficiency AnemiaHereditary Hemolytic Anemia+8 more Massachusetts General Hospital 100
Not applicableLooking for participantsNCT05983991What this trial is testingStudy for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline MutationWho this might be right forGATA2 Gene Mutation Institut Claudius Regaud 150
Not applicableLooking for participantsNCT06785077What this trial is testingGenetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP InhibitorsWho this might be right forLeukemia, Myeloid, AcuteMyeloid DysplasiaOvarian Epithelial Cancer European Institute of Oncology 157
Large-scale testing (Phase 3)Study completedNCT04948333What this trial is testingAsciminib Treatment Optimization in ≥ 3rd Line CML-CPWho this might be right forChronic Myelogenous Leukemia Novartis Pharmaceuticals 199
Not applicableActive Not RecruitingNCT03918655What this trial is testingMIF Involvement in AMLWho this might be right forAcute Myeloid Leukemia Assistance Publique - Hôpitaux de Paris 186
Not applicableLooking for participantsNCT06764459What this trial is testingMolecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic TreatmentsWho this might be right forMyeloid Leukemia, Acute IRCCS Azienda Ospedaliero-Universitaria di Bologna 20
Not applicableNot Yet RecruitingNCT05969821What this trial is testingClonal Hematopoiesis of Immunological SignificanceWho this might be right forImmune System DiseasesAutoimmune DiseasesInflammation+13 more Assistance Publique - Hôpitaux de Paris 5,000
Not applicableStudy completedNCT06463639What this trial is testingFLT3 Clonal Evolution in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia National Taiwan University Hospital 1,213
Not applicableLooking for participantsNCT07500441What this trial is testingDigital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AMLWho this might be right forAcute Myeloid Leukemia (AML) Peking University People's Hospital 100